Liz Parrish

We can not control the aging reversal to a specific year today, that will come in the future. It is hypothesized that you will not reverse in physical appearance to less than a young adult. We see this in mice as well.

But do remember that the most important risk factor for cancer is growing older. Most cancers occur in people over the age of 65.

Currently, we are working to deliver our anti-aging gene therapies to terminally ill people for compassionate care. Although, in the future we think that preventative medicine against aging would begin at a much younger age.

You have little to no response to AAV the first time your body sees it. If you used the same vector twice you would want to bump up immunosuppression. I believe there will be many new ways to deliver genes in the future as well.

Our goal is to build laboratories that will have the mission of a cGMP product at a reduced cost.

Yes, we are looking into gene therapies for immune cells to target senescent cells.

I was awake for the therapy, it was documented by a film crew. I am proud to have taken part of helping millions of people even if it has bad results.

Hundreds of people are undergoing gene therapy today. There are no known neurological issues.

I hope that the image of gene therapy is changing. It seems to be.

I think gene therapy and nanotechnology go hand in hand.

The gene therapies on my body are to measure the effects on humans. There is plenty of animal research to support these gene therapies but no one was conducting human tests.

Gene therapy technology is much like computing technology. We had to build the super computer which cost $8 million in 1960. Now everyone has technologies that work predictably and at a cost the average person can afford.